Published in J Cereb Blood Flow Metab on November 01, 1996
Kinetic analysis of [11C]McN5652: a serotonin transporter radioligand. J Cereb Blood Flow Metab (1999) 0.89
Quantitative cerebral H2(15)O perfusion PET without arterial blood sampling, a method based on washout rate. Eur J Nucl Med Mol Imaging (2003) 0.79
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol (1997) 10.06
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med (1995) 4.44
Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16
Age differences in the frontal lateralization of verbal and spatial working memory revealed by PET. J Cogn Neurosci (2000) 3.66
Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science (2001) 3.48
Spatial working memory in humans as revealed by PET. Nature (1993) 3.42
Dissociating verbal and spatial working memory using PET. Cereb Cortex (1996) 3.18
Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal (1997) 3.10
Verbal Working Memory Load Affects Regional Brain Activation as Measured by PET. J Cogn Neurosci (1997) 3.00
Inhibition in verbal working memory revealed by brain activation. Proc Natl Acad Sci U S A (1998) 3.00
The role of parietal cortex in verbal working memory. J Neurosci (1998) 2.89
Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med (1994) 2.76
Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry (1999) 2.38
Magnetic resonance imaging documentation of coexistent traumatic locked facets of the cervical spine and disc herniation. J Neurosurg (1993) 2.27
Components of verbal working memory: evidence from neuroimaging. Proc Natl Acad Sci U S A (1998) 2.15
History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology (2009) 2.01
Lumbar disk disease: pathophysiology, management and prevention. Am Fam Physician (1993) 2.01
Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med (1993) 1.93
Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.89
Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr (1995) 1.88
Spatial versus Object Working Memory: PET Investigations. J Cogn Neurosci (1995) 1.88
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology (1999) 1.86
Stereotactic navigation for placement of pedicle screws in the thoracic spine. Neurosurgery (2001) 1.83
Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Neurology (2010) 1.79
Emergency magnetic resonance imaging of cervical spinal cord injuries: clinical correlation and prognosis. Neurosurgery (1999) 1.77
Age differences in behavior and PET activation reveal differences in interference resolution in verbal working memory. J Cogn Neurosci (2000) 1.76
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex. Ann Neurol (2000) 1.73
Spinal cord astrocytomas: results of therapy. Neurosurgery (1992) 1.67
Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol (2001) 1.67
Mutual information for automated unwarping of rat brain autoradiographs. Neuroimage (1997) 1.60
The interspinous method of posterior atlantoaxial arthrodesis. J Neurosurg (1991) 1.56
Outcome after laminectomy for lumbar spinal stenosis. Part II: Radiographic changes and clinical correlations. J Neurosurg (1994) 1.54
Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine. J Cereb Blood Flow Metab (1999) 1.49
A comparison of cerebral blood flow and glucose metabolism in olivopontocerebellar atrophy using PET. Neurology (1995) 1.47
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol (1996) 1.45
Comparison of human cerebral activation pattern during cutaneous warmth, heat pain, and deep cold pain. J Neurophysiol (1996) 1.42
Neuropsychological changes in olivopontocerebellar atrophy. Arch Neurol (1990) 1.42
Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med (1995) 1.42
Technetium-99m-N1-(2-mercapto-2-methylpropyl)-N2-(2-propargylthio-2- methylpropyl)-1,2-benzenediamine (T691): preclinical studies of a potential new tracer of regional cerebral perfusion. J Nucl Med (1992) 1.40
Isolation of specific interference processing in the Stroop task: PET activation studies. Neuroimage (1997) 1.40
Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab (1991) 1.40
Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol (1996) 1.35
Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology (2000) 1.33
Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology (1996) 1.32
The neural basis of task-switching in working memory: effects of performance and aging. Proc Natl Acad Sci U S A (2001) 1.30
Limbic activation and psychophysiologic responses to aversive visual stimuli. Interaction with cognitive task. Neuropsychopharmacology (2000) 1.28
Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients. Alcohol Clin Exp Res (1993) 1.27
"Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med (1993) 1.26
Caspar plate fixation for the treatment of complex hangman's fractures. Neurosurgery (1992) 1.25
Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images. J Nucl Med (1994) 1.25
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease. Exp Neurol (2003) 1.23
Positron emission tomographic analysis of cerebral structures activated specifically by repetitive noxious heat stimuli. J Neurophysiol (1994) 1.20
PET evidence for an amodal verbal working memory system. Neuroimage (1996) 1.19
The effect of emotional content on visual recognition memory: a PET activation study. Neuroimage (1998) 1.19
Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology (2003) 1.18
Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. J Nucl Med (1996) 1.18
Crossed cerebellar diaschisis: occurrence and resolution demonstrated with PET during carotid temporary balloon occlusion. AJNR Am J Neuroradiol (1992) 1.16
Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake. J Nucl Med (1996) 1.15
Response of the μ-opioid system to social rejection and acceptance. Mol Psychiatry (2013) 1.15
Imaging the vesicular monoamine transporter. Adv Neurol (2001) 1.15
Cerebellar and frontal hypometabolism in alcoholic cerebellar degeneration studied with positron emission tomography. Ann Neurol (1990) 1.15
Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. Eur J Pharmacol (2000) 1.14
Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. J Cereb Blood Flow Metab (1997) 1.13
Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain. J Cereb Blood Flow Metab (1999) 1.11
Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse (2000) 1.09
Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology (1999) 1.08
The neurochemistry of therapeutics: levodopa pharmacodynamics in Parkinson's disease. Ann Neurol (2001) 1.08
Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders. Psychopharmacology (Berl) (2001) 1.08
Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biol Psychiatry (2001) 1.08
Performance comparison of parameter estimation techniques for the quantitation of local cerebral blood flow by dynamic positron computed tomography. J Cereb Blood Flow Metab (1985) 1.07
PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. J Nucl Med (1995) 1.07
REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology (2003) 1.06
Consequences of high-dose steroid therapy for acute spinal cord injury. J Trauma (1997) 1.06
Effects of nicotine on regional cerebral glucose metabolism in awake resting tobacco smokers. Neuroscience (2000) 1.06
In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter. J Med Chem (1996) 1.05
Regional cerebral blood flow effects of nicotine in overnight abstinent smokers. Biol Psychiatry (2001) 1.04
Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA. Neurology (2003) 1.03
Decreased striatal monoaminergic terminals in Huntington disease. Neurology (2000) 1.03
Striatal dopaminergic abnormalities in human cocaine users. Am J Psychiatry (1999) 1.02
Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography. Ann Neurol (1999) 1.02
Role of FDG PET/CT in imaging of renal lesions. J Med Imaging Radiat Oncol (2010) 1.02
PET evidence for multiple strategies of categorization. Cogn Affect Behav Neurosci (2001) 1.02
The effect of graded aversive stimuli on limbic and visual activation. Neuropsychologia (2000) 1.00
Localization of muscarinic m3 receptor protein and M3 receptor binding in rat brain. Neuroscience (1994) 1.00